Loading...

Wayland Group Corp.

MRRCFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Wayland Group Corp. MRRCF Peers

See (MRRCF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MRRCF$0.00+0.00%2.4KN/A-$0.01N/A
MKGAF$130.20+0.39%56.5B17.08$7.61+1.91%
MKKGY$25.77+0.27%55.7B16.95$1.52+1.95%
TKPHF$27.72+3.82%43.6B60.26$0.46+4.80%
HLNCF$4.82-0.41%43.3B22.93$0.21+1.81%
IPSEY$30.79-1.47%40.7B24.83$1.24+0.83%
SDZNY$58.56+2.20%25.2B-2929.75-$0.02+1.15%
TEVJF$17.80+0.00%20.4B-15.48-$1.15N/A
ESALY$61.51-2.11%17.6B20.54$3.00N/A
SGIOY$8.24-2.49%14B12.11$0.68+1.93%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MRRCF vs MKGAF Comparison

MRRCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MRRCF stands at 2.4K. In comparison, MKGAF has a market cap of 56.5B. Regarding current trading prices, MRRCF is priced at $0.00, while MKGAF trades at $130.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MRRCF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.08. In terms of profitability, MRRCF's ROE is -2.21%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, MRRCF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for MRRCF.

Stock Price Comparison

Loading...

Frequently Asked Questions

;